Literature DB >> 28949086

Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison.

Piergiuseppe Agostoni1,2, Stefania Paolillo3, Massimo Mapelli1, Piero Gentile4, Elisabetta Salvioni1, Fabrizio Veglia1, Alice Bonomi1, Ugo Corrà5, Rocco Lagioia6, Giuseppe Limongelli7, Gianfranco Sinagra4, Gaia Cattadori8, Angela B Scardovi9, Marco Metra10, Valentina Carubelli10, Domenico Scrutinio6, Rosa Raimondo11, Michele Emdin12,13, Massimo Piepoli14, Damiano Magrì15, Gianfranco Parati16,17, Sergio Caravita17, Federica Re18, Mariantonietta Cicoira19, Chiara Minà20, Michele Correale21, Maria Frigerio22, Maurizio Bussotti23, Fabrizio Oliva24, Elisa Battaia24, Romualdo Belardinelli25, Alessandro Mezzani5, Luigi Pastormerlo12, Marco Guazzi26, Roberto Badagliacca27, Andrea Di Lenarda28, Claudio Passino12,13, Susanna Sciomer27, Elena Zambon4, Giuseppe Pacileo7, Roberto Ricci9, Anna Apostolo1, Pietro Palermo1, Mauro Contini1, Francesco Clemenza19, Giovanni Marchese22, Paola Gargiulo3, Simone Binno14, Carlo Lombardi10, Andrea Passantino6, Pasquale Perrone Filardi29.   

Abstract

AIMS: Risk stratification in heart failure (HF) is crucial for clinical and therapeutic management. A multiparametric approach is the best method to stratify prognosis. In 2012, the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score was proposed to assess the risk of cardiovascular mortality and urgent heart transplantation. The aim of the present study was to compare the prognostic accuracy of MECKI score to that of HF Survival Score (HFSS) and Seattle HF Model (SHFM) in a large, multicentre cohort of HF patients with reduced ejection fraction. METHODS AND
RESULTS: We collected data on 6112 HF patients and compared the prognostic accuracy of MECKI score, HFSS, and SHFM at 2- and 4-year follow-up for the combined endpoint of cardiovascular death, urgent cardiac transplantation, or ventricular assist device implantation. Patients were followed up for a median of 3.67 years, and 931 cardiovascular deaths, 160 urgent heart transplantations, and 12 ventricular assist device implantations were recorded. At 2-year follow-up, the prognostic accuracy of MECKI score was significantly superior [area under the curve (AUC) 0.781] to that of SHFM (AUC 0.739) and HFSS (AUC 0.723), and this relationship was also confirmed at 4 years (AUC 0.764, 0.725, and 0.720, respectively).
CONCLUSION: In this cohort, the prognostic accuracy of the MECKI score was superior to that of HFSS and SHFM at 2- and 4-year follow-up in HF patients in stable clinical condition. The MECKI score may be useful to improve resource allocation and patient outcome, but prospective evaluation is needed.
© 2017 The Authors. European Journal of Heart Failure © 2017 European Society of Cardiology.

Entities:  

Keywords:  HFSS; Heart failure; MECKI score; Prognosis; Risk score; SHFM

Mesh:

Year:  2017        PMID: 28949086     DOI: 10.1002/ejhf.989

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  18 in total

1.  An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best?

Authors:  Barbara S Doumouras; Douglas S Lee; Wayne C Levy; Ana C Alba
Journal:  Curr Heart Fail Rep       Date:  2018-02

Review 2.  Exercise physiology in left ventricular assist device patients: insights from hemodynamic simulations.

Authors:  Libera Fresiello; Christoph Gross; Steven Jacobs
Journal:  Ann Cardiothorac Surg       Date:  2021-05

Review 3.  The New Heart Failure Association Definition of Advanced Heart Failure.

Authors:  Marco Metra; Elisabetta Dinatolo; Nicolò Dasseni
Journal:  Card Fail Rev       Date:  2019-02

Review 4.  Highlights in heart failure.

Authors:  Daniela Tomasoni; Marianna Adamo; Carlo Mario Lombardi; Marco Metra
Journal:  ESC Heart Fail       Date:  2019-12

5.  The MECKI score initiative: Development and state of the art.

Authors:  Elisabetta Salvioni; Alice Bonomi; Federica Re; Massimo Mapelli; Irene Mattavelli; Giuseppe Vitale; Filippo M Sarullo; Pietro Palermo; Fabrizio Veglia; Piergiuseppe Agostoni
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

6.  Future developments in the MECKI score initiative.

Authors:  Andrew Js Coats
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

7.  Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device.

Authors:  Scott C Silvestry; Claudius Mahr; Mark S Slaughter; Wayne C Levy; Richard K Cheng; Damian M May; Eleni Ismyrloglou; Stelios I Tsintzos; Edward Tuttle; Keziah Cook; Erica Birk; Aparna Gomes; Sophia Graham; William G Cotts
Journal:  ASAIO J       Date:  2020-08       Impact factor: 2.872

8.  Monitoring of biomarkers in heart failure.

Authors:  Ilaria Spoletini; Andrew J S Coats; Michele Senni; Giuseppe M C Rosano
Journal:  Eur Heart J Suppl       Date:  2019-12-31       Impact factor: 1.803

9.  Heart rate and blood pressure monitoring in heart failure.

Authors:  Piotr Ponikowski; Ilaria Spoletini; Andrew J S Coats; Massimo F Piepoli; Giuseppe M C Rosano
Journal:  Eur Heart J Suppl       Date:  2019-12-31       Impact factor: 1.803

10.  Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction.

Authors:  Elisabetta Salvioni; Ugo Corrà; Massimo Piepoli; Sara Rovai; Michele Correale; Stefania Paolillo; Mario Pasquali; Damiano Magrì; Giuseppe Vitale; Laura Fusini; Massimo Mapelli; Carlo Vignati; Rocco Lagioia; Rosa Raimondo; Gianfranco Sinagra; Federico Boggio; Lorenzo Cangiano; Giovanna Gallo; Alessandra Magini; Mauro Contini; Pietro Palermo; Anna Apostolo; Beatrice Pezzuto; Alice Bonomi; Angela B Scardovi; Pasquale Perrone Filardi; Giuseppe Limongelli; Marco Metra; Domenico Scrutinio; Michele Emdin; Lucrezia Piccioli; Carlo Lombardi; Gaia Cattadori; Gianfranco Parati; Sergio Caravita; Federica Re; Mariantonietta Cicoira; Maria Frigerio; Francesco Clemenza; Maurizio Bussotti; Elisa Battaia; Marco Guazzi; Francesco Bandera; Roberto Badagliacca; Andrea Di Lenarda; Giuseppe Pacileo; Claudio Passino; Susanna Sciomer; Giuseppe Ambrosio; Piergiuseppe Agostoni
Journal:  ESC Heart Fail       Date:  2020-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.